PB Fintech · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Paisabazaar credit-linked revenue declined 8% YoY to INR 130 crore versus management's own guidance of 0-10% growth. The regulator's advisory on unsecured lending has impacted the industry for multiple quarters, and while management expects recovery in H2, there is no guaranteed timeline. Analyst Sachin Salgaonkar explicitly questioned whether the business model needs revisiting.
Savings product mix shifted toward lower-margin ULIPs (take rates now ~60% of company average), compressing overall take rates despite growing premium. If ULIP mix continues to increase, revenue may grow slower than premium for an extended period. Management acknowledged 25% of business at 15% margin decline = ~4% overall impact.
Management expressed concern that the current healthcare model (focused on revenue per bed) is unsustainable, with room rents of INR 60,000-66,000 making policies unaffordable for the average buyer (INR 6-10 lakh annual income). Unless this model is fixed, price hikes will continue annually and eventually suppress industry growth.
Yashish Dahiya stated he has spent 50%+ of his time on hospital/claims integration over six months but admitted no concrete plan is ready. Analyst Srinath directly asked about leveraging 15-20% of retail hospital claims through Policybazaar customers, but management could only commit to 'another quarter' before sharing details. This represents a significant deferred growth opportunity.
